Scentian Bio
A new way to sense the world
New Zealand · $7.3M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- scentianbio.com
- Total Funding
- $7.3M
- Last Round
- $3.5M Series AJan 2020
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Scentian Bio is a New Zealand biotech spinout from Plant & Food Research that combines synthetic biology with AI to create biosensors mimicking the smell receptors of insects. Founded by Dr Andrew Kralicek after 19 years researching insect odorant receptors, the company holds patents on technology to synthetically produce these receptor proteins at scale and connect them to a transducer, delivering a super-sensitive, real-time 'digital nose' capable of measuring thousands of volatile compounds for food, agriculture, and industrial applications.
Summary
Scentian Bio is a Biotech company based in New Zealand. It has raised $7.3M in total across 3 rounds, most recently a $3.5M Series A round in Jan 2020. Investors include Bill & Melinda Gates Foundation, Finistere Ventures and Toyota Ventures.
Funding History
2020 (est.)
Sign up to see all 3 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/scentian-bio"><img src="https://indexed.vc/api/badge/company/scentian-bio" alt="Scentian Bio on Indexed.vc" width="260" height="76" /></a>